Sudarshan Pharma to Divest 51% Stake in Ishwari Healthcare

Sudarshan Pharma Industries Ltd announced its Board of Directors has approved the divestment of 2,09,100 equity shares, representing 51% of the paid-up share capital, in its subsidiary Ishwari Healthcare Private Limited. The transaction is expected to be completed by December 31, 2026. Following the divestment, Ishwari Healthcare will cease to be a subsidiary of Sudarshan Pharma. The exact consideration for the sale will be determined after a valuation of Ishwari Healthcare. The company is currently seeking a buyer for the stake at a competitive price.